key: cord-0839826-52fjusqj
authors: Shah, Zinnia; Gohar, Umar Farooq; Jamshed, Iffat; Mushtaq, Aamir; Mukhtar, Hamid; Zia-UI-Haq, Muhammad; Toma, Sebastian Ionut; Manea, Rosana; Moga, Marius; Popovici, Bianca
title: Podophyllotoxin: History, Recent Advances and Future Prospects
date: 2021-04-19
journal: Biomolecules
DOI: 10.3390/biom11040603
sha: 3090935252dd17c719a13e5fee5132fe0e01d09e
doc_id: 839826
cord_uid: 52fjusqj

Podophyllotoxin, along with its various derivatives and congeners are widely recognized as broad-spectrum pharmacologically active compounds. Etoposide, for instance, is the frontline chemotherapeutic drug used against various cancers due to its superior anticancer activity. It has recently been redeveloped for the purpose of treating cytokine storm in COVID-19 patients. Podophyllotoxin and its naturally occurring congeners have low bioavailability and almost all these initially discovered compounds cause systemic toxicity and development of drug resistance. Moreover, the production of synthetic derivatives that could suffice for the clinical limitations of these naturally occurring compounds is not economically feasible. These challenges demanded continuous devotions towards improving the druggability of these drugs and continue to seek structure-optimization strategies. The discovery of renewable sources including microbial origin for podophyllotoxin is another possible approach. This review focuses on the exigency of innovation and research required in the global R&D and pharmaceutical industry for podophyllotoxin and related compounds based on recent scientific findings and market predictions.

Podophyllotoxin is an aryltetralin-type lignan isolated from species of Podophyllum [1, 2] . Two most common sources are the rhizomes of Podophyllum peltatum (American mayapple) and Sinopodophyllum hexandrum Royle (Barberry family) [1, 3] . These perennial herbs are distributed widely across the Himalayan region and Western China [4] [5] [6] [7] . Plants with high podophyllotoxin or podophyllotoxin-analogues' content have been extensively used in traditional medicine since a long time in different cultures [8] [9] [10] [11] . This remarkable molecule was first isolated in 1880 by Podwyssotzki [12] [13] [14] [15] , while it had already been described as early as in 1753 by Linnaeus [16] . Due to its remarkable biological activity, podophyllotoxin has remained a subject of various investigations ever since. It is mainly obtained from the alcohol-soluble fraction of Podophyllum species, called podophyllin-a bitter tasting resin.

The podophyllotoxin extract has been documented for its use as a laxative, and as a remedy for various medical complications such as gonorrhea, tuberculosis, menstrual disorders, psoriasis, dropsy, cough, syphilis and venereal warts [8] [9] [10] [11] . The podophyllotoxinfamily is now confirmed to elicit various curative properties such as mitotoxic, neurotoxic, Figure 1 . The sequential discovery of podophyllotoxin-group of drugs. FDA approved anticancer drugs etoposide, teniposide and etopophos were derived from the parent compound podophyllotoxin, which was originally extracted from mayapple plant as a curative for various diseases. As the side-effects for podophyllotoxin and its primary derivatives became evident, less toxic derivatives such as TOP-53, NK611, GL-331, azatoxin and various others were designed and synthesized.

Podophyllotoxin has a five-ring system (ABCDE) having four chiral centers (C1-C4) in a row- Figure 2 . There are five important structural characteristics of most podophyllotoxin species: (1) a tetracyclic group going from dioxole ring (A) to the lactone ring (D); (2) four oxygen atoms located at the functional groups lactone, methoxys, secondary alcohol and oxoles; (3) ring E with alpha-configuration located at position 1; (4) four asymmetrical adjacent centers and (5) the unique stereochemical properties of C4 define the molecules' mechanism of action [31, 32] . Studies have revealed, rational modification at C4 can improve the molecule's topoisomerase II inhibitory activity, drug resistance profile, water solubility and antimitotic activities [33] . The lactone ring is known to exhibit transconfiguration, which easily epimerizes in low basic conditions [32] . 

Derivatives of this multifaceted molecule are synthesized as properties of its four rings. Ring A, for instance is not essential for the exhibition of antimitotic activity, and aromatization of ring C may cause displacement of axially positioned ring E-leading to a loss of cytotoxic property. Structural diversity hence brings many attractive medicinal properties and a comprehensive insight to the molecule's mechanism of action. These derivatives were first introduced by Schreier through selective cleavage of ring A to produce a 6, 7-dihydroxy derivative (compound A), which was further methylated with diazomethane to produce yet another derivative (compound B) shown in Figure 3 [34] . Schreier's methods were later on slightly modified to produce a large group of podophyllotoxin derivativescompound I-XXfrom compound C, Figure 3 . However, the structural modifications are not alone to contribute towards the novelty of the derivatives, instead, changes in the chemical skeleton of podophyllotoxin cyclo-lignan add particularity to each individual derivative. With slight modifications in the podophyllotoxin skeleton, the ring-A-open compounds appeared biologically less active than podophyllotoxin itself [35] ; functional studies indicate that an intact A-ring system is important for the compounds' DNA topoisomerase II (dtopII) inhibiting activity. Based on these findings, three crucially significant domains in the parent pharmacophore model were reported [36] . Modifications at these domains further revealed the unexplored potential of novel clinically applicable derivatives (shown in Figure 4 )with a mechanism of action distinct to that of the previously well-established derivative; etiposide [37] . The paucity of studies on B-ring modifications in podophyllotoxin led the investigation of α-peltatin and β-peltatin. These two compounds ( Figure 5 ) exhibited significant antiviral and antitumor activities. In order to investigate the influence of B-ring substitutions and modifications, a series of ester-and ether-derivatives of both structures were prepared by various researchers but were reported to be biologically less active than their parent compounds [38] [39] [40] [41] [42] [43] . Structures of alpha-peltatin and beta-peltatin. These two B-ring modified podophyllotoxin derivatives are known to exhibit significant antiviral and antitumor activities. The B-ring modified pharmacophore was identified from these compounds and was taken further to synthesize more derivatives-as shown bracketed-none of which elicited any clinical efficacy.

Several C-ring modified podophyllotoxin analogues have also been subjected to extensive research. Unlike the two natural C-aromatized lignans; justicidin A and diphyllin; the many synthetic C-ring aromatized compounds were prepared but reported to have no cytotoxic activities. This observation proposed that the axial E-ring conformation was lost during synthetic preparations. The loss of the axial E-ring conformation is now known to be directly linked to the loss of molecule's cytotoxic and dtopII inhibiting activity [44] . Notably, however, delactonized analogues of podophyllotoxin-apopicropodophyllotoxin; and its beta-isomer-β-apopicropodophyllotoxin give strong antimitotic activities, otherwise indicating the untrammelled antimitotic potential of podophyllotoxin-like compounds in the absence of the lactone ring [45] [46] [47] . The antitumor activity of podophyllotoxin and its derivatives is mainly due to the ability to inhibit tubulin polymerization [48] , which is a property of the axially placed E-ring. The cis-fused lactone rings, however, modulating its selectivity from tubulin to IGF-1 (insulin-like growth factor I) receptor to trigger cell death [49] [50] [51] .

Transfused γ-lactone D ring is also strict requirement for podophyllotoxin's antitumor activity. Since it is susceptible to isomerization, the opening of this lactone ring is undesirable for it limits the physiological lifetime of these compounds and their biological effectiveness as well. A series of delactonized D-ring derivatives were prepared [52] [53] [54] [55] [56] [57] and studied by various researchers, most of which were found to be less cytotoxic than the parent compound itself. However, an ethyl hydrazide derivative ( Figure 6 ) was found to retain its clinical efficacy but was discontinued due to severe adverse aftereffects [58] . Studies that later discovered immunosuppressive ability of these derivatives were attempted to revive D-ring modified podophyllotoxin-antitumor drug preparations [59, 60] . 4 -d-β-DMEP (4 -d-β-Demethylepipodophyllotoxin) is a natural lignin, which is used in chemotherapy as an aglycon of etoposide [61, 62] . 4 -d-α-DMEP is a novel biological derivative of 4 -d-β-DMEP reported by Jia et al. (2020) , which has a higher antitumor activity [63] . 

A variety of plant species belonging to approximately over 60 vascular families have been reported as viable sources of podophyllotoxin, which includes genera other than the genus Podophyllum, such as Diphylleia and Dysosma (beriberidaceae), Haplophyllum (Rutaceae), Thuja, Jeffersonia, Anthriscus (Apiaceae), Callitris and Thujopsis (Cupresceae), Hernandia (Hernandiaceae), Nepeta and Thymus (Labiaceae), Catharanthus (Apocynaceae), Teucrium, Hyptis (Verbenaceae), Commiphora (Burseraceae), Polygala (Polygalaceae), Linun (Linaceae), Juniperus and Cassia (Fabaceae) [17, 26] . Podophyllotoxin is found accumulated mostly in the roots and rhizomes of these plants but have also been detected in their stems, roots, seeds, fruits, leaves, woody parts and, in some cases, from the associated endophytic microorganisms. However, Podophyllum hexandrum Royle has been reported to contain higher amounts of podophyllotoxin (4.3%) compared to other podophyllotoxin producing plant species [66] . The various podophyllotoxin producing plant species have been tabulated below (Table 1) . 

The understanding of plant pathways is comparatively absolute to the microbial pathways characterized to date. Plant genes that are involved the biosynthetic pathways of various plant-derived clinical drugs remain obscure, hence preventing the transfer of which to heterologous hosts for industrial production. The complete biosynthetic pathway ( Figure 8) for podophyllotoxin was elucidated only recently in 2015, allowing more facile access to its natural and processed, clinically significant derivatives-otherwise difficult to synthesize on an industrial scale [108] . 

Biotechnological procedures for podophyllotoxin production were introduced as a means to overcome its large scale production challenges, which includes the extinction of various podophyllotoxin-plant sources, slow growth of plant sources, exacting constructs and low yields. Micro-organisms, however, demonstrate an enormity of biodiversity, which overdo those of plants. Fungal sources, for instance, have rendered to be a much fruitful alternative to somatic embryogenesis, tissue culturing or macropropagation techniques. The main fungal sources used for industrial podophyllotoxin production are; Trametes hirsuta [110] , Fusarium oxysporum [111] , Fungus Alternaria [112] , Mucor fragilis [113] , Fusarium solani [114] , Trametes histuria [110] , Sebacina vermifera, Phialocephala fortinii [115] and Aspergillus fumigatus [101, 116] . The endophytic sources of podophyllotoxin are also tabulated below Table 2 [111] describes the process of podophyllotoxin production from Fusarium oxysporum, which lives on Juniperus recurva. The outcome suggests F. oxysporum to be a promising contender for industrial podophyllotoxin production. In 2009, the specie Juniperus communis L. Horstmann was also found to produce deoxypodophyllotoxin, which shared remarkable structural relativity to the lignan of podophyllotoxin [117] . No bacterial sources of podophyllotoxin have yet been identified. 

Studies report five major parameters, which influence the biosynthesis of podophyllotoxin; these include luminosity, chilling units/hours, macro-and micro-nutrients and soil's pH and nutrient availability. Any fluctuation in the strength of which can result in altered podophyllotoxin yields. In the presence of red-light, for instance, increased the overall product formation in comparison to light of other wavelengths [123] ; likewise, chilling units set at 4 • C were reported to have caused a 5-folds increase in product yield. The variation in concentrations of macro-and micro-nutrients such as glucose, nitrogen, NO 3 − , PO 4 3− , Na + , Fe 2+ , Mn 2+ , etc., has shown similar correlation with podophyllotoxin production. Moreover, the acidity or alkalinity levels of the soil in cases for podophyllotoxin producing plants also demonstrate yield modifications. These parameters are tabulated and discussed below Table 3 . 

Podophyllotoxin and its derivatives possess a wide-spectrum of pharmacological potential. The achievability of broad chemical modifications brings the podophyllotoxin pharmacophore its diverse applicability as a medicinal compound-tabulated in Table 4 . Antineoplastic activity is the most outstanding of all its clinical properties. Various studies validate podophyllotoxin derivatives including etopophos, teniposide, etoposide, etoposide phosphate, GL331, NK-611, TOP53 and NPF as anticancer drugs [64, [128] [129] [130] [131] [132] . Many clinical studies have reported the efficacy of these compounds against various forms of cancer including lung cancer, Wilmstumours, diverse types of genital tumors such as carcinoma verrucosus and for non-Hodgkin lymphoma, multiform glioblastoma lymphoma and nonlymphocytic leukemia [17] . Podophyllotoxin has also shown activity against various (multi) drug resistant tumor cells. As an example, Hu and coworkers presented a 4-β-anilino-podophyllotoxin derivative as a potential anticancer drug against the KB/VCR cells in both conditions; in vivo and in vitro [133] . For the development of new anticancer drugs, podophyllotoxin containing analogues are of prime focus in recent studies. Ming et al. [134] explained that an endophytic fungus named as Dysosma versipellis has both anticancer and antimicrobial properties. The aqueous extract of Podophyllum peltatum [41] fractionated by reverse-phase chromatography was observingly the most active component that was found to cause the inhibition in the replication process of herpes simplex type 1 virus and measles.

Moreover, picropodophyllotoxin, deoxypodophyllotoxin and peltatins are also determined as useful antiviral compounds [135] [136] [137] . Activity against Sindbis and cytomegalovirus has also been recorded [138] . They either decrease the capacity of the infected cell to release virus or restrain these viruses in the replication cycle at an essential early stage, following the virus absorption into cells. Not only this, podophyllotoxin can also be used for treating Condyloma acuminatum that is usually caused by HPV (papilloma virus) [139] and for treating other perianal and venereal warts [140] . With a goal to achieve better therapeutic effectiveness, cocktail therapies are currently in use with other registered chemotherapeutic agents, combined with additional techniques that are beneficial in fighting against cancer and other viral infections. Podophyllotoxins with interferon therapy has shown greater effectivity against genital human infections, combination with cisplatin, on the other hand, is useful for treating neuroblastomas. Recently a study reports the study progression of etoposide in phase II clinical trials (ClinicalTrials NTC04356690) as a redeveloped drug to treat COVID-19 patients suffering with cytokine storm complication [141] . Similarly, in recent years podophyllotoxin derivatives have shown some interesting insecticidal activities against the larvae of Brontispa longissima and Mythimna separata [142] . Furthermore, derivatives are also being synthesized and used for the treatment of malaria and psoriasis [143] . Podophyllotoxins also hold dermatological significance and prove to be potential therapeutic agents for psoriasis vulgaris. Podophyllotoxin exhibited considerable ichthyotoxic activity and phyto growth inhibitory activities, even though the effects were weaker as compared to deoxy podophyllotoxin, in all cases observed [144, 145] .

Besides the major antiviral and anticancer activities, podophyllotoxin and its derived compounds have also exhibited some further interesting activities such as antitrypanosomal activity, antimelanocortin-4 receptor (MC4R) activity, antioxidative activity, immunosuppressive, antioxidative, antispasmogenic, hypolipidemic, emetic, laxative and anti-inflammatory activity. Moreover, during the last century, many trials were carried out in an attempt to cure diseases such as syphilis, cough, gonorrhea, dropsy, gout, psoriasis, tuberculosis, tumor, menstrual disorders and venereal warts by using podophyllotoxins. According to Hartwell et al. (1951) , podophyllotoxin is particularly abundant in the genus Podophyllum that has been utilized since ancient times as bothanthelminthic and cathartic agents, for medicinal purposes [3] . Podophyllotoxin is demonstrated as a promising and relatively safe drug, for treating genital warts and is also an active ingredient of registered wartec ointments and condylox liquids. Ethyl-2-(3 -methyl-4methoxybenzoyl)-3-(4" methoxyphenol)-cyclopropane-1carboxylic acid and Ethyl-2-(3 -methyl-4methoxybenzyol-3-1 3", 4"-dimethoxyphenyl)-cyclopropanecarboxylic acid, both of them showed significant antibacterial activity [147] Antitumour activity VP 16-213 (NSC-141540) Activity was checked against L1210 ascites tumour in N/D mice In 24 hours, divided treatment after every 3 hours, resulted in significant cure, hence, VP 16-213 is a cell cycle specific drug [148] Insecticidal activity 20 podophyllotoxin analogues were tested Activity was checked against fifth-instar larvae of Brontispa longissima in vivo Among 20 analogues Deoxypodophyllotoxin showed more protential for insecticidal activity than a commercial insecticide (toosendanin) [149] Antineoplastic activity

Activity was checked against human leukemia cancer cells as a multifunctional anti-MDR agent

Podophyllotoxin-indirubin hybrid (Da-1) showed potential to overcome drug resistance. It is a novel hybrid havingpotent antiproliferative activity [150] Cyclolignans, derived from podophyllotoxin Activity was checked againstA-549 human lung carcinoma, P-388 murine leukemia and HT-29 colon carcinoma A number of substances were active in assay at concentrations below 1 pM; deoxypodophyllotoxin being the most potent compound in all cases [151] 

In the past decade, numerous attempts have been globally to produce derivatives or compositions of podophyllotoxins in order to overcome their natural dose-limiting toxicity, poor biodistribution and low aqueous solubility. These inventions have found extensive application for effective chemotherapeutic purposes. These inventions have succeeded at demonstrating sufficient activity and can considerably contribute to future studies, some of these new derivatives are tabulated below (Table 5 ). 

Elevated antitumor activity than podophyllotoxin or 4 demethylepipodophyllotoxin [159] The great interest of institutional researchers and pharmaceutical companies is also validated by a surge in number of patents protecting various inventions involving podophyllotoxin. Searching the term "podophyllotoxin" gave 93,446 results in the Google patent database while 26,582 in the Patent Lens database with the first patent application filed in 1967-12-06 and granted in 1970-08-18. When "podophyllotoxin" is used as keywords for the the patents and/or patent applications annual filed (Figure 9) , key applicant companies (Figure 10) , key inventors (Figure 11 ), and key owners based in US ( Figure 12 ) [160, 161] 

Novel approaches towards structure optimization and the finding of alternative sources can help unravel less toxic, more efficient and easy to yield podophyllotoxin and its derivatives. Being known for decades as the main bioactive compound in various traditional medicinal formulas, these compounds were later approved for clinical use against a number of health conditions. In the recent pandemic, various known drugs were repurposed against the novel coronavirus strain 2019. Amongst this struggle of trial and error, etoposide-a podophyllotoxin derivative well cited for its antineoplastic activityhas also been redeveloped to manage cytokine storm complication in COVID-19 patients. This finding opens new potential for podophyllotoxin, its derivatives and its congeners to be explored. For as the growing demand for podophyllotoxin is increasing, plant sources are proving to be an unreliable option for the future, this explains the exigency of utilizing microbial biotransformation as a considerable approach along with the need of devoted effort towards rationally designing the new generation of the group of podophyllotoxinderived compounds. Data Availability Statement: All the data produced here is available and can produced when required.

The authors declare no conflict of interest.

Podophyllotoxin: Distribution, sources, applications, and new cytotoxic derivatives

Components of Podophyllin. V. The Constitution of Podophyllotoxin

Lignans, Chemical, Biological and Clinical Properties

Discovery of Podophyllin

Current Research Status of Podophyllotoxin Lignans

A Study of the Resources of Chinese Podophyllin Plants

Present Situation of Studies on Resources of Podophyllotoxin

Research Progress in Sinopodophyllum emodi

Biological Activity of Lignans

Podophyllotoxin derivatives: Drug discovery and development

Anticancer Agents from Natural Products

The active constituents of podophyllotoxin

On the active constituents of podophyllin

Pharmakologische Studien uber podophyllum peltatum

Recent Advances in the Chemistry and Biology of Podophyllotoxins

The isolation of podophyllotoxin glucoside

The isolation of 4 -Demethylpodophyllotoxin glucoside from rhizomes podophyllum emodi wall

Chemistry and Pharmacology of podophyllum glucosides and derivatives. I. Arzneim

Mitosis-inhibiting substances. XXI. Synthesis of epipodophyllotoxin b-D-glucopyranoside

Mitosis-inhibiting substances. glycosidation process.II. Glycosides of 4"-demethylepipodophyllotoxin

Synthesis and antimitotic activity of glycosidic lignan derivatives related to podophyllotoxin

The clinical pharmacology of etoposide. An update

The Chemical and Biological Route from Podophyllotoxin Glucoside to Etoposide: Ninth Cain Memorial Award Lecture

Podophyllotoxin: A novel potential natural anticancer agent

Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611 A study by the AIO groups PHASE-I and APOH

A novel podophyllotoxin-derived compound GL331 is more potent than its congener VP-16 in killing refractory cancer cells

A novel topoisomerase GL331 preferentially induces DNA cleavage at (C/G)T sites and can cause telomere DNA damage

Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent

Medicinal Plant Biotechnology; CAB International

Podophyllotoxin derivatives: Current synthetic approaches for new anticancer agents

Polyether-modified poly (acrylic acid): Synthesis and applications

Partial synthese der 6, 7-Dimethoxy-Analogen von Podophyllotoxin

New 4 beta-substituted aniline derivatives of 6,7-O,O-demethylene-4'-Odemethylpodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II

Dichloropo-dophenazine, Benzopodophenazine, and Their 4b-p-Nitroaniline Derivatives as Novel DNA Topoisomerase II Inhibitors

Three-Dimensional Quantitative Structure-Activity Relationship Study of 4'-O-Demethyl-epipodophyllotoxin Analogs Using the Modified CoMFA/q2 -GRS Approach

The isolation of a-peltatin glucoside from the rhizomes of Podophyllum peltatum L

Podophyllotoxin and their Glycosidic derivatives

An Investigation of the Antiviral Activity of Podophyllum peltatum

Inhibition of human DNA topoisomerase II by podophyllotoxin and alpha-peltatin analogs

Inhibition of human DNA topoisomerase II by cytotoxic ether and ester derivatives of podophyllotoxin and alpha-peltatin

Synthetic Ring C Aromatized Podophyllotoxin Analogues as Potential Inhibitors of Human DNA Topoisomerase II

Synthesis of Podophyllotoxin & related analogues: Part II-Synthesis of ß-apopicrophyllin analogues with modified Hydroaromatic ring-B

Synthesis of Podophyllotoxin & related analogues: Part III-Synthesis of ß-apopicrophyllin analogues with modified lactone ring

The effects of unsaturated factors on ring C to chemical Properties of podophyllotoxin analogues

Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors

Biotransformation of podophyllotoxin to picropodophyllin by microbes

Cyclolignans as inhibitors of the insulin-like growth factor-I receptor

Picropodophyllin induces down regulation of the insulin-like growth factor 1 receptor: Potential mechanistic involvement of Mdm2 and beta-arrestin

Non-enolizable podophyllotoxin derivatives

Preparation of 2-substituted podophyllotoxin derivatives

A high yield preparation of 2-fluoropodophyllotoxin

Synthesis, and Biological Testing of 4b-Anilino-2-fluoro-4'-demethylpodophyllo-toxin Analogues as Cytotoxic and Antiviral Agents

Synthesis of Sterically Fixed Podophyllotoxin. Liebigs Ann

New gamma-lactone ring-modified arylamino etoposide analogs as inhibitors of human DNA topoisomerase II

Immunosuppressive cyclolignans

Novel D-ring analogues of podophyllotoxin as potent anti-cancer agents

9-Deoxopodophyllotoxin derivatives as anti-cancer agents

Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study

Six enzymes from mayapple that complete the biosynthetic pathway to the etoposide aglycone

A novel podophyllotoxin derivative with higher anti-tumor activity produced via 4 -demethylepipodophyllotoxin biotransformation by Penicillium purpurogenum

Podophyllotoxin: Current Perspectives

A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor

Expression analysis of biosynthetic pathway genes vis-à-vis podophyllotoxin content in Podophyllum hexandrum Royle

phenylpropanoids and polyacetylenes from Chaerophyllum aureum L. (Apiaceae)

A novel podophyllotoxin lignan from Justicia heterocarpa

A new podophyllotoxin-type lignan from Dysosma versipellis var. tomentosa

Bioprospecting for Podophyllotoxin

COVID-19: Recent Developments in Therapeutic Approaches

Endophytic fungus from Sinopodophyllum emodi (Wall.) ying that produces Podophyllotoxin

Enhanced production of podophyllotoxin, kaempferol, and quercetin from callus culture of Dysosma pleiantha (Hance) woodson: An endangered medicinal plant

Antitumor agents from Bursera microphylla (Burseraceae) I. Isolation and characterization of deoxypodophyllotoxin

A New Lignan from Commiphora incisa Resin1

Cytotoxic constituents of Bursera permollis

Bioactive constituents from roots of Bursera tonkinensis

Absolute configuration of podophyllotoxin related lignans from Bursera fagaroides using vibrational circular dichroism

Lignans from Juniperus thurifera

Desoxypodophyllotoxin, the cytotoxic principle of Callitris columellaris F. Muell

Production of 5-methoxypodophyllotoxin in cell suspension cultures of Linum flavum L. Tissue Organ Cult

Isolation of podophyllotoxin from Callitrus drummondii

Podophyllotoxin from Juniperus species; savinin

Production of podophyllotoxin in Juniperus chinensis callus cultures treated with oligosaccharides and a biogenetic precursor in honour of Professor GH Neil towers 75th birthday

Bioactive constituents of Thuja occidentalis

Bioproduction of Podophyllotoxin and Related Aryltretralin-Lignans in Hairy Root Cultures of Linum Flavum L

Podophyllotoxin and essential oil profile of Juniperus and related species

Study of cytotoxic activity, podophyllotoxin, and deoxypodophyllotoxin content in selected Juniperus species cultivated in Poland

Aerial parts of Callitris species as a rich source of deoxypodophyllotoxin

Callitris intratropica RT Baker & HG Smith as a novel rich source of deoxypodophyllotoxin

Investigation of the lignan content in extracts from Linum, Callitris and Juniperus species in relation to their in vitro antiproliferative activities

Production of podophyllotoxin by plant tissue cultures of Juniperus virginiana

Aryltetralin lignans from Linum flavum and Linum capitatum

Formation of lignans in suspension cultures of Linum album

β-Peltatin 6-O-methyltransferase from suspension cultures of Linum nodiflorum

Comparison of different extraction methods for the determination of podophyllotoxin and 6-methoxypodophyllotoxin in Linum species

Lignan accumulation in cell cultures of Linum strictum ssp. strictum L

Linum mucronatum: Organ to organ lignan variations

Influence of methyl jasmonate on podophyllotoxin and 6-methoxypodophyllotoxin accumulation in Linum album cell suspension cultures

Aryltetralin-lignan formation in two different cell suspension cultures of Linum album: Deoxypodophyllotoxin 6-hydroxylase, a key enzyme for the formation of 6-methoxypodophyllotoxin

Co-culture of arbuscular mycorrhiza-like fungi (Piriformospora indica and Sebacina vermifera) with plant cells of Linum album for enhanced production of podophyllotoxins: A first report

Selection methodology with scoring system: Application to Mexican plants producing podophyllotoxin related lignans

Metabolic profiling of lignan variability in Linum species of section Syllinum native to Bulgaria

Podophyllotoxin and 6-methoxy podophyllotoxin production in hairy root cultures of Liunm mucronatum ssp. mucronatum

Podophyllotoxin production by cell cultures of Linum thracicum ssp. thracicum Degen elicited with methyl jasmonate and salicylic acid

Optimization of cell/tissue culture of Linum persicum for production of lignans derivatives including Podophyllotoxin

Effect of in vitro morphogenesis on the production of podophyllotoxin derivatives in callus cultures of Linum album

A patent review

Historical and Introductory Aspects of Carotenoids

The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related aryltetralin ligans

Isolation and identification of an endophytic strain of Fusarium oxysporum producing podophyllotoxin from Juniperus recurva

Fermentation conditions of Sinopodophyllum hexandrum endophytic fungus on production of podophyllotoxin. Food Ferment. Ind

Mucor fragilis as a novel source of the key pharmaceutical agents podophyllotoxin and kaempferol

P1, a new endophytic podophyllotoxin-producing fungus from roots of Podophyllum hexandrum

Endophyte Fungal Isolates from Podophllum peltatum Produce Podophyllotoxin

Chemometric Evaluation of the Anti-cancer Pro-drug Podophyllotoxin and Potential Therapeutic Analogues in Juniperus and Podophyllum Species

Aspergillus fumigatus, an endophytic fungus from Juniperus communis L. Horstmann as a novel source of the anticancer pro-drug deoxypodophyllotoxin

Screening and identification of endophytic fungi producing podophyllotoxin compounds in Sinopodophyllum hexandrum stems

Diversity and bioactive potential of culturable fungal endophytes of Dysosma versipellis; a rare medicinal plant endemic to China

Podophyllotoxin and its analogues from the endophytic fungi derived from Dysosma veitchii

An endophytic fungus producing a substance analogous to podophyllotoxin isolated from Diphylleia sinensis

Select of producing podophyllotoxin endophytic fungi from podophyllin plant

The effect of light on gene expression and podophyllotoxin biosynthesis in Linum album cell culture

Chilling temperature stimulates growth, gene over-expression and podophyllotoxin biosynthesis in Podophyllum hexandrum Royle

Effect of major nutrients on podophyllotoxin production in Podophyllum hexandrum suspension cultures

Relationship between podophyllotoxin accumulation and soil nutrients and the influence of Fe 2+ and Mn 2+ on podophyllotoxin biosynthesis in Podophyllum hexandrum tissue culture

Impact of Soil Nutrients and Environmental Factors on Podophyllotoxin Content among 28 Populations of Podophyllum Hexandrum

A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins

Biotechnological aspects of the production of the anticancer drug podophyllotoxin

Conformational analysis of podophyllotoxin and its congeners. Structure-activity relationship in microtubule assembly

Present and Future of Carotenoids Research

Drugs that inhibit tubulin polymerization: The particular case of podophyllotoxin and analogues

Novel 4 beta-anilino-podophyllotoxin derivatives: Design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents

A New Benzenoid Derivative from an Endophytic Fungus in Peperomia sui

Biological activities of lignans

New treatments for genital warts less than ideal: Abstract and commentary

Inhibitory Effects of Podophyllotoxin Derivatives on Herpes Simplex Virus Replication

The antiviral action of lignans

Human leukocyte interferon-alpha versus podophyllotoxin in cream for the treatment of genital warts in males. A placebo-controlled, double-blind, comparative study

Podophyllotoxin in the treatment of genital warts

Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy

Podophyllotoxin Derivatives Show Activity against Brontispa Longissima Larvae

Medicinal Uses for Podophyllotoxin

A clinical study of CPH 82 vs. methotrexate in early rheumatoid arthritis

Antitumor Properties of Podophyllotoxin and Related Compounds

Challenges at the Time of COVID-19: Opportunities and innovations in the Antivirals from Nature

Cytotoxic Lignans from Fruits of Cleistanthus indochinensis: Synthesis of Cleistantoxin Derivatives

Antibacterial Activity of Synthetic Precursors of Podophyllotoxin

Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia

Podophyllotoxin-derived insecticidal agents: Part XIII-Evaluation of insecticidal activity of podophyllotoxin derivatives against Brontispa longissima

Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukemia cancer cells as multifunctional anti-MDR agents

Podophyllotoxins Derivatives. U.S. Patent US-8158809-B2

New Use of Specific Cyclolignans

Novel Podophyllotoxin Derivatives, the Production. There of and the Use of the Same in Therapeutics

Podophyllotoxin Derivative with 4-Position Nitrogen Substitution and Preparation Method and Application There of

Linked Podophyllotoxin Derivatives as Potential Anticancer Agents

Gem-Difluorinated C-Glycoide Compounds Derived from Podophyllotoxin, Their Preparation and Their Application

4-Sulfur Substituted Podophyllotoxin Derivative and Preparation Method There of and Use There of

Sulfur-Substituted Podophyllotoxin Derivative, Synthesis Method There of, and Use There of

Patents Lens Database

Google Patents Database